This is an overwhelming trend for the Ducks

This is an overwhelming trend for the Ducks.Stationary hockey leads to so many bad things on the ice. Penalties are always the result when players don't move their feet, but lately the Ducks are finding there are other negatives to standing around.Their passing, for one, is in the toilet.When players stand around waiting for the puck to find their stick, the puck becomes a predictable target for defenders to pick off.Turnovers become abundant and the defense and goaltending units are left vulnerable. It's a vicious cycle of events the Ducks can cure by simply moving their feet.. The entire Ducks roster has no confidence in one another.Until they are able to trust their teammates, their coaching staff, and their management, they're going to continue to struggle game after game.At this rate, it doesn't look good.. SEATTLE, WA, Jan 07 (MARKET WIRE) Pacific Biometrics, Inc.

(OTCBB: PBME) ("PBI" or "the Company"), aleading provider of specialty central laboratory and contract researchservices, today announced that the Company has paid all of the remainingprincipal and interest outstanding on its borrowings from Laurus MasterFund, Ltd ("Laurus") and Franklin Funding, Inc. ("Franklin Funding").In May 2004 and January 2005, the Company entered into financingarrangements with Laurus that consisted of the issuance of $2.5 millionand $1.5 million, respectively, in secured convertible notes. Theremaining principal and interest due under the May 2004 Note was paidJuly 28, 2008. The final paymentof principal and interest was paid in the amount of $46,462 on December29, 2008."The retirement of both the Laurus and Franklin Funding debt facilitiesclearly illustrates the substantial progress that our Company has made inrecent years, and our balance sheet is now essentially debt-free with theexception of various outstanding capital equipment leases," stated RonHelm, Chairman and Chief Executive Officer of Pacific Biometrics, Inc. "Aswe previously noted when announcing first quarter operating results, PBIgenerated $372,000 in cash flow from operating activities during the threemonths ended September 30, 2008, which represented a 175 improvement whencompared with the prior-year quarter.

These operating cash flows, alongwith cash generated in the October-December period, allowed us to retirethe remainder of the outstanding Laurus and Franklin Funding debt."About Pacific Biometrics, Inc. The Companyprovides expert services in the areas of cardiovascular disease, diabetes,osteoporosis, arthritis, and nutrition. PBI's clients include many of the world's largestpharmaceutical, biotech, and diagnostic companies.Pacific Biomarkers, Inc., incorporated February 1, 2008 as a wholly-ownedsubsidiary of PBI, focuses specifically on the emerging field of biomarkerassay development and testing. Services include validating and performingligand-binding assays for novel clinical biomarkers, immunogenicitytesting, and multiplex testing.PBI is headquartered in Seattle, Washington, and its common stock tradeson the OTC Bulletin Board under the symbol "PBME." For more informationabout PBI, visit the company's web site at Harbor Statement under the Private Securities Litigation Reform Actof 1995: This press release includes forward-looking statements including,but not limited to, the growth in revenues and backlog that may resultfrom established and new services, including our biomarker services, ourstrategic planning and business development plans, impacts on ourfinancial results, our future growth, and the viability and acceptance ofour products and services in the market.

These risks include, but are not limited to, our ability tobid on and win laboratory services contracts, client changes or earlyterminations of studies, variability in backlog, the success of ourmarketing and business development efforts, competition in the industry,and our ability to manage growth, as well as the risks and other factorsset forth in our periodic filings with the U.S. Securities and ExchangeCommission (including our Form 10-K for the year ended June 30, 2008).For additional information, please contact:Ron HelmCEO(206) 298-0068orRJ Falkner & Company, Inc.Investor Relations Counsel(800) 377-9893Email ContactCopyright 2009, Market Wire, All rights reserved.-0-. ATLANTA, Jan. Since then, newand established companies have contracted with Porter to deliver richknowledge about their markets and customers Porter's special area ofexpertise has been Healthcare IT. From complex regulations and shiftinggovernment requirements to the adoption of new technologies like electronicmedical records, Healthcare IT is a world unto its own. Porter has been awell-known brand in the Healthcare marketplace for more than a decade, workingwith hundreds of clients.Since 1953, Billian's HealthDATA (BHD) has been the leading provider ofcomprehensive market intelligence to the healthcare industry. From thegroundbreaking national directory, The Hospital Blue Book(TM) to onlinehealthcare databases and Healthcare IT market intelligence, BHD is committedto being the most dynamic resource in the industry today."As our chairman, Doug Billian, said, this acquisition is more of a mergerbetween two companies that complement each other in ways that provide terrificvalue for clients," said Jim Borneman, president, Billian Publishing.